Impilo completed the investment in Qufora.

Impilo, a Nordic investment company, completed the investment in Qufora, which produces clinical aids for patients with chronic bowel conditions. Financial terms were not disclosed. "We have followed Qufora for several years and are highly impressed by the company’s development, which is largely grounded in Qufora’s strong values, strategy, and culture. This is encapsulated by a highly skilled management team and staff who show a deep passion for Qufora’s products and mission. With this partnership, we can jointly accelerate the company’s future expansion," Nicholas Hooge, Impilo Partner.